Profile data is unavailable for this security.
About the company
Nanosonics Limited is an Australia-based infection prevention company. The Company's principal activities include the manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. It is focused on the research, development, and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generate a sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. Its products include trophon2, Nanosonics Auditpro, and trophon EPR. The Company's trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics AuditPro is an automated digital system that combines clinician infection prevention decision making, with the Trophon 2 device infection control workflow data, and patient procedure information.
- Revenue in AUD (TTM)198.63m
- Net income in AUD20.68m
- Incorporated2000
- Employees470.00
- LocationNanosonics Ltd7-11 Talavera Road, Macquarie ParkSYDNEY 2113AustraliaAUS
- Phone+61 28063-1600
- Fax+61 29418-3743
- Websitehttps://www.nanosonics.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orthocell Ltd | 8.85m | -8.57m | 354.44m | -- | -- | 23.89 | -- | 40.04 | -0.0375 | -0.0375 | 0.0397 | 0.0599 | 0.2862 | 2.31 | 9.20 | -- | -27.70 | -28.14 | -34.17 | -33.47 | 68.98 | 71.87 | -96.78 | -167.82 | 4.78 | -- | 0.0381 | -- | 36.41 | 61.65 | -19.30 | -- | 45.43 | -- |
| Paragon Care Ltd | 3.62bn | 20.57m | 430.38m | 0.00 | 20.93 | 1.30 | 8.54 | 0.119 | 0.0124 | 0.0124 | 2.18 | 0.1993 | 3.02 | 11.90 | 10.33 | -- | 1.72 | 1.79 | 4.47 | 4.07 | 9.04 | 8.90 | 0.5688 | 0.6081 | 0.6155 | 1.77 | 0.4699 | -- | 21.72 | 73.23 | 151.52 | -- | 18.34 | -- |
| Imricor Medical Systems Inc | 1.15m | -55.48m | 490.83m | -- | -- | 13.78 | -- | 425.22 | -0.2052 | -0.2052 | 0.0042 | 0.1111 | 0.0237 | 1.13 | 2.64 | -- | -113.72 | -103.39 | -123.12 | -119.90 | -133.44 | -154.65 | -4,806.09 | -2,687.85 | 25.62 | -1.11 | 0.5073 | -- | 55.86 | 8.44 | -31.23 | -- | -26.55 | -- |
| EBR Systems Inc | 261.68k | -65.81m | 620.85m | -- | -- | 8.10 | -- | 2,372.54 | -0.1926 | -0.1926 | 0.0008 | 0.1705 | 0.002 | -- | 0.1353 | -- | -49.32 | -60.71 | -54.45 | -74.76 | 49.75 | -- | -25,147.49 | -- | 8.80 | -12.84 | 0.4495 | -- | -- | -- | -16.44 | -- | 2.46 | -- |
| 4DMedical Ltd | 5.85m | -30.07m | 940.69m | -- | -- | 13.34 | -- | 160.71 | -0.0714 | -0.0714 | 0.0138 | 0.138 | 0.0545 | 0.4858 | 0.8787 | -- | -27.99 | -32.98 | -34.63 | -40.38 | 92.07 | 86.20 | -513.72 | -1,237.52 | 0.8383 | -- | 0.0629 | -- | 55.91 | 36.56 | 16.42 | -- | 3.07 | -- |
| Polynovo Ltd | 127.73m | 13.21m | 949.91m | 301.00 | 72.10 | 11.41 | 59.70 | 7.44 | 0.0191 | 0.0191 | 0.1837 | 0.1205 | 1.08 | 0.367 | 5.88 | 424,352.20 | 11.19 | 2.17 | 14.29 | 2.71 | 96.63 | 94.89 | 10.35 | 2.10 | 2.25 | 7.87 | 0.1707 | 0.00 | 21.96 | 41.91 | 151.17 | -- | 9.45 | -- |
| Nanosonics Ltd. | 198.63m | 20.68m | 1.40bn | 470.00 | 68.93 | 6.67 | 48.74 | 7.05 | 0.0669 | 0.0669 | 0.6425 | 0.6913 | 0.7792 | 2.23 | 5.05 | 422,612.80 | 8.11 | 6.48 | 9.45 | 7.53 | 78.22 | 77.93 | 10.41 | 8.69 | 5.19 | -- | 0.0353 | 0.00 | 16.83 | 14.70 | 59.39 | 15.32 | 35.13 | -- |
| Ansell Ltd | 3.09bn | 156.67m | 4.95bn | 15.72k | 31.62 | 1.63 | 17.99 | 1.60 | 1.07 | 1.07 | 21.14 | 20.85 | 0.6129 | 2.26 | 8.74 | 196,459.50 | 3.17 | 5.33 | 3.73 | 6.38 | 41.18 | 38.27 | 5.17 | 7.98 | 1.01 | 8.01 | 0.2889 | 48.30 | 23.71 | 4.42 | 32.81 | -8.53 | 1.35 | 0.4863 |
| Holder | Shares | % Held |
|---|---|---|
| Selector Funds Management Ltd.as of 31 Jul 2025 | 24.24m | 7.99% |
| UBS Asset Management (Australia) Ltd.as of 31 Jul 2025 | 16.02m | 5.28% |
| Yarra Funds Management Ltd.as of 31 Jul 2025 | 16.01m | 5.27% |
| Hyperion Asset Management Ltd.as of 07 Oct 2025 | 15.54m | 5.12% |
| ECP Asset Management Pty Ltd.as of 21 Mar 2025 | 15.15m | 4.99% |
| First Sentier Investors (Australia) IM Ltd.as of 17 Dec 2024 | 12.74m | 4.20% |
| The Vanguard Group, Inc.as of 03 Sep 2025 | 9.11m | 3.00% |
| State Street Bank & Trust Co.as of 26 Sep 2024 | 7.27m | 2.40% |
| State Street Global Advisors, Australia, Ltd.as of 26 Sep 2024 | 6.91m | 2.28% |
| Australian Foundation Investment Co. Ltd. (Invt Mgmt)as of 31 Jul 2025 | 5.72m | 1.88% |
